UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The impact of direct antiviral agents on the development and recurrence of hepatocellular carcinoma

Liver international, 2017-01, Vol.37 (S1), p.136-139

2017

Volltextzugriff (PDF)

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2008-01, Vol.47 (1), p.97-104

2008

Volltextzugriff (PDF)

Identification of Coding and Long Noncoding RNAs Differentially Expressed in Tumors and Preferentially Expressed in Healthy Tissues

Cancer research (Chicago, Ill.), 2019-10, Vol.79 (20), p.5167-5180

2019

Volltextzugriff (PDF)

Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma

Gut, 2012-10, Vol.61 (10), p.1481-1487

2012

Volltextzugriff (PDF)

Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents

Viruses, 2019-05, Vol.11 (5), p.406

2019

Volltextzugriff (PDF)

OncomiRs miR-106a and miR-17 negatively regulate the nucleoside-derived drug transporter hCNT1

Cellular and molecular life sciences : CMLS, 2021-12, Vol.78 (23), p.7505-7518

2021

Volltextzugriff (PDF)

Identification of Dhx15 as a Major Regulator of Liver Development, Regeneration, and Tumor Growth in Zebrafish and Mice

International journal of molecular sciences, 2024-04, Vol.25 (7), p.3716

2024

Volltextzugriff (PDF)

Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH

Frontiers in immunology, 2024-05, Vol.15, p.1400553

2024

Volltextzugriff (PDF)

Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide

Biomedicine & pharmacotherapy, 2024-01, Vol.170, p.116038-116038, Article 116038

2024

Volltextzugriff (PDF)

miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma

Cells (Basel, Switzerland), 2022-08, Vol.11 (17), p.2673

2022

Volltextzugriff (PDF)

Real-time PCR improves Helicobacter pylori detection in patients with peptic ulcer bleeding

PloS one, 2011-05, Vol.6 (5), p.e20009-e20009

2011

Volltextzugriff (PDF)

Liver FoxO1 overexpression is positively associated with the degree of liver injury in cirrhotic patients

Advances in laboratory medicine, 2023-09, Vol.4 (3), p.218-226

2023

Volltextzugriff (PDF)

La sobreexpresión de FoxO1 en el hígado esta positivamente asociada al grado de daño hepático en pacientes cirróticos

Advances in laboratory medicine, 2023-09, Vol.4 (3), p.227-235

2023

Volltextzugriff (PDF)

Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cells

Biomarker research, 2024-04, Vol.12 (1), p.38-38, Article 38

2024

Volltextzugriff (PDF)

miRNA Expression and HCC Occurrence in HCV Cirrhotic Patients Treated with Direct Acting Antivirals

Livers, 2024-06, Vol.4 (2), p.275-286

2024

Volltextzugriff (PDF)

Low Baseline Plasma L-Glutamine Concentration Identifies Hepatocellular Carcinoma Patients at High Risk of Developing Early Gastrointestinal Adverse Events during Sorafenib Treatment

Gastrointestinal disorders (Basel, Switzerland), 2022-07, Vol.4 (3), p.141-152

2022

Volltextzugriff (PDF)

Hepatitis C virus and liver disease: Global transcriptional profiling and identification of potential markers

Hepatology (Baltimore, Md.), 2003-12, Vol.38 (6), p.1458-1467

2003

Volltextzugriff (PDF)

MicroRNA Analysis for Outcome Prediction in Hepatitis B Virus–Related Liver Cancer

Gastroenterology (New York, N.Y. 1943), 2010-04, Vol.138 (4), p.1624-1626

2010

Volltextzugriff (PDF)

K-ras Mutations in DNA Extracted From the Plasma of Patients With Pancreatic Carcinoma: Diagnostic Utility and Prognostic Significance

Journal of clinical oncology, 1999-02, Vol.17 (2), p.578-584

1999

Volltextzugriff (PDF)

Liver Cancer Emergence Associated with Antiviral Treatment: An Immune Surveillance Failure?

Seminars in liver disease, 2017-05, Vol.37 (2), p.109-118

2017

Volltextzugriff (PDF)

FRI-491-YI Targeting inflammasome activation by sorafenib/regorafenib as strategy to enhance efficacy in hepatocellular carcinoma therapy

Journal of hepatology, 2024-06, Vol.80, p.S424-S425

2024

Volltextzugriff (PDF)

FRI-494-YI Cabozantinib induces mtDNA-dependent cytotoxicity through cGas-STING signaling in experimental hepatocellular carcinoma

Journal of hepatology, 2024-06, Vol.80, p.S425-S426

2024

Volltextzugriff (PDF)

Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection

Hepatology (Baltimore, Md.), 1993-11, Vol.18 (5), p.1121-1126

1993

Volltextzugriff (PDF)

Mitochondrial damage, revealed as key factor in cabozantinib efficacy against hepatocellular carcinoma, is potentiated by the BH3-mimetic navitoclax

Journal of hepatology, 2022-07, Vol.77, p.S652

2022

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(79)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(51)
Humans
(37)
Gastroenterology & Hepatology
(24)
Male
(24)
Liver Cancer
(22)
Female
(21)
Hepatocellular Carcinoma
(21)
Biological And Medical Sciences
(20)
Medical Sciences
(19)
Middle Aged
(19)
Aged
(18)
Tumors
(17)
Oncology
(13)
Animals
(11)
Gastroenterology. Liver. Pancreas. Abdomen
(11)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(10)
Carcinoma, Hepatocellular - Metabolism
(9)
Liver Neoplasms - Metabolism
(9)
Liver Neoplasms - Pathology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The impact of direct antiviral agents on the development and recurrence of hepatocellular carcinoma

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma

Identification of Coding and Long Noncoding RNAs Differentially Expressed in Tumors and Preferentially Expressed in Healthy Tissues

Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma

Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents

OncomiRs miR-106a and miR-17 negatively regulate the nucleoside-derived drug transporter hCNT1

Identification of Dhx15 as a Major Regulator of Liver Development, Regeneration, and Tumor Growth in Zebrafish and Mice

Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH

Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide

Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity

miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma

Real-time PCR improves Helicobacter pylori detection in patients with peptic ulcer bleeding

Liver FoxO1 overexpression is positively associated with the degree of liver injury in cirrhotic patients

La sobreexpresión de FoxO1 en el hígado esta positivamente asociada al grado de daño hepático en pacientes cirróticos

Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cells

miRNA Expression and HCC Occurrence in HCV Cirrhotic Patients Treated with Direct Acting Antivirals

Low Baseline Plasma L-Glutamine Concentration Identifies Hepatocellular Carcinoma Patients at High Risk of Developing Early Gastrointestinal Adverse Events during Sorafenib Treatment

Hepatitis C virus and liver disease: Global transcriptional profiling and identification of potential markers

MicroRNA Analysis for Outcome Prediction in Hepatitis B Virus–Related Liver Cancer

K-ras Mutations in DNA Extracted From the Plasma of Patients With Pancreatic Carcinoma: Diagnostic Utility and Prognostic Significance

Liver Cancer Emergence Associated with Antiviral Treatment: An Immune Surveillance Failure?

FRI-491-YI Targeting inflammasome activation by sorafenib/regorafenib as strategy to enhance efficacy in hepatocellular carcinoma therapy

FRI-494-YI Cabozantinib induces mtDNA-dependent cytotoxicity through cGas-STING signaling in experimental hepatocellular carcinoma

Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection

Mitochondrial damage, revealed as key factor in cabozantinib efficacy against hepatocellular carcinoma, is potentiated by the BH3-mimetic navitoclax

Suchergebnisse filtern